TQMC has acquired wide Domain Knowledge and Experience. You can FREELY access it here and here

DISCLAIMER: This matter here is a guide only. For authentic and up-to-date information, please contact TQMC.

The DIRECTIVES and STANDARDS listed here may have been subsequently REVISED . You must refer to the CURRENT REVISION and AMENDMENTS if any.

Monday, July 12, 2010

Regulatory requirements

  • The 3rd Pharmaceutical Regulatory Affairs Summit Asia will bring together TOP Regulatory Affairs Executives coming from Global Pharmas and leading Biotechs to discuss central issues on Regulations in ASEAN with updates on Harmonization and spotlight on Clinical Trials, Biologics/Biosimilars and Marketing.
  • It is the ONLY event in Asia to have truly substantial country-by-country updates and over ten (10) valuable case studies from pharma, generics and biotechs on how regulatory hurdles can be most efficiently addressed.

Take full advantage of practical learning and detailed how-to’s during the interactive workshops:

Pre-Conference Workshop:

Obtain a comprehensive understanding of recent changes in the application process to facilitate successful FDA approval applications for biosimilars and follow-on branded generics. Understand key insights into regulatory requirements and processes for US FDA approval of drugs and biologics.
Led by: Dr Duu-Gong Wu, Executive Director, Consulting Division, PharmaNet Development Group International (PDGI), USA and former US FDA Deputy Division Director

  • Post-Conference Workshops

  • (B) Understanding Regulatory Affairs for GMP & Manufacturing
    Get in depth understanding of the regulatory issues and concerns. You will discover insights in how regulatory knowledge can help manufacturing functions to continually improve, qualify for the GMP accreditations and foster communication among industry and regulatory authorities.
    Led by: Dr. Shivraj Dasari, Vice President – Quality Management & Regulatory Affairs, InnoBio Ventures Sdn.Bhd, Malaysia

  • (C) Regulatory Affairs for Generics Companies

  • Learn useful insights into the generics regulatory framework. Discussions include the scope of the regulatory profession and the role and responsibilities of the regulatory professional. This session is designed to provide an understanding of the regulatory environment of generics companies.
    Led by: Zoher Sihorwala, Vice President – Global Regulatory Affairs, Dr. Reddy’s Laboratories Ltd., India

  • To view the main conference programme and full workshop agenda or to book online, please visit the website, email or call us on +65 6508 2401.

Testimonials from past attendees:
It was interactive, speaker well prepared” - Sanofi Aventis -
Excellent topics and speakers
- Novartis -
Informative. Learnt about how other countries work & the difference in expectations” - KK Women and Children’s Hospital -

No comments:

Post a Comment